Page 50 - Pharma

Bio Innovation Centre opened at Tiruvananthapuram

Under 'Make in India', biotechnology to grow to $ 100 billion by 2025, says Dr Harsh Vardhan

Patent Office rejects Novartis' patent claim on diabetes drug

The company was refused a patent for a modified release formulation of its diabetes drug, Vildagliptin, which it markets under the brand name of Galvus

Strong IPR regime can only entice companies to invest in India: Swiss minister

Johann Schneider Ammann, Swiss economic affairs minister, urges Indian government to remove the difficulties faced by pharma companies in testing and marketing facilities

Dr Reddy's launches stroke drug Somazina

With the launch of Somazina and its recent acquisition of Nootropil, through the UCB brands' acquisition, the company is looking to consolidate its presence in neurology segment

Strides Arcolab receives US FDA approval for HIV drug

The Bangalore based drug manufacturer has received approval for lamivudine and zidovudine tablets USP, 150 mg/ 300 mg

India & Mongolia to ink pact for alternative medicines

The government has also extended the tenure of the MoU signed between India and China on cooperation in traditional medicine

Opto Circuits launches automated external defibrillator in US and Canada

The company's Powerheart G5 is first FDA-cleared AED to combine fully auto shock delivery, fast shock times, and dual-language functionality

Dr Reddy's Satish Reddy to head National Safety Council

He will over the chairmanship from Venu Srinivasan - chairman of Sundaram-Clayton Group which includes TVS Motor Company - who steered the workings of the council since July 2011

Lupin forays into Brazil by buying Medquimica

The acquisition is expected to shore up Lupin's position in the Latin American pharmaceuticals market

SRF to set up specialty chemicals plant in Dahej

The company has reported 86% increase in consolidated net profit after tax (PAT) at Rs 303 crore for the fiscal ended March 31, 2015

Torrent acquires dermatological product maker Zyg Pharma

The acquisition will help Torrent to strengthen its position in niche dermatological segment especially in the developed markets like US and Europe

Omkar Speciality Chemicals receives orders worth Rs 100 crore

The company has received concrete indents in April, 2015 from its customers in India as well as from overseas for orders close to Rs 100 cr to be executed during the current financial year

IOL Chemicals receives approval for metformin in Europe

The certificate, issued by EDQM, will enable IOLCP to sell metformin hydrochloride in Europe resulting into increase in higher value added export turnover and margin

BLK Super Speciality Hospital inks collaboration pact with Uzbekistan govt

The Delhi-based private hospital will help in capacity building of Uzbekistan-based RRCEM for specialised emergency care

Cancer & infectious diseases to drive adoption of point-of-care medical sensor

Infectious diseases pose a big challenge for medical sensors, mainly on account of the sheer number of pathogens, says Lux Research report

Glenmark receives tentative US FDA approval for psoriasis drug

The company has been granted tentative approval for calcipotriene cream, 0.005% - the generic version of Dovonex cream, which registered an annual sales of $92.8 mn in the US

Fortis divests stake in Singapore-based RadLink to Fullerton Healthcare for SGD 111 mn

The deal is expected to be completed on or about May 12, 2015

Hilleman Labs extends thermostable technology to more vaccines

Last year, Hilleman had initiated R&D of thermostable formulations of oral rotavirus vaccine, which offered longer stability of the vaccine even in varying temperature

Zydus Group joins hand with US-based NIH for developing leishmaniasis vaccine

The company will collaborate with NIH to investigate the importance of vector salivary proteins in the development of leishmaniasis vaccine

Suven Life receives product patents for CNS drug from overseas authorities

The company has secured patents from Australia, Europe, Hong Kong, Israel and Norway for its NCEs used in the treatment of disorders associated with neurodegenerative diseases